FUTURE: Phase II prospective non-randomized diagnostic study of FAPI PET imaging and liquid biopsy in bladder cancer
Sponsor: Universita' Vita-salute S. Raffaele
Phase: 2
Disease: Urothelial carcinoma of the bladder, High-grade non-muscle-invasive bladder cancer, Muscle-invasive bladder cancer
EU trial number: 2026-526990-40-00
Population: Adults aged ≥18 years with high-grade non-muscle-invasive or muscle-invasive urothelial bladder cancer, ECOG 0–1, eligible for imaging, blood and urine collection, and possible surgery/systemic therapy.
Register Investigator Interest
Interested in offering this trial to suitable patients?